The use of Agnes for any aesthetic procedures in the US is considered an off-label procedure. Approved as a general clearance and no indication for any specific procedures under US FDA. K192728
Agnes Radiofrequency (RF), has been introduced in the global aesthetic practices for minimally invasive dermatological procedures. After the approval from the US FDA in 2017, Agnes RF has been adopted to Plastic Surgery, Dermatology, and Aesthetic Practices in the US as the backbone technology of non-surgical aesthetic procedures.
The protective features of the micro-insulation and the length of the electrode were developed over two decades of clinical studies from our key opinion leaders in global practices. Needles of different lengths and configurations allow your staff to customize the treatment based on the patient’s unique needs.